Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-23T15:59:26.370Z Has data issue: false hasContentIssue false
  • English
  • Français

Tobacco Industry Use of Corporate Social Responsibility Tactics as a Sword and a Shield on Secondhand Smoke Issues

Published online by Cambridge University Press:  01 January 2021

Lissy C. Friedman
Get access Rights & Permissions [Opens in a new window]

Extract

Corporate social responsibility has become a potential path to legitimacy and improved public relations for both companies that produce mainstream products and those that sell vice, such as the tobacco industry. Since the early 1990s, the tobacco industry has sought to bridge the gap between the public perception it has earned as a merchant of death and its goal of gaining corporate legitimacy and normality by promoting programs, positions, and policies it hopes the general public will believe are aimed at preventing or mitigating some of the societal ills that smoking causes, such as youth smoking. There is, however, an intractable problem that corporate social responsibility efforts can mask but not resolve: the tobacco industry’s products are lethal when used as directed, and no amount of public relations or funding of ineffective youth smoking prevention programs can reconcile that fundamental contradiction with ethical corporate citizenship. The focus of this study is to better understand the tobacco industry’s corporate social responsibility efforts and to assess whether there has been any substantive change in the way it does business with regard to the issue of exposure to secondhand smoke.

Type
Independent
Information
Journal of Law, Medicine & Ethics , Volume 37 , Issue 4 , Winter 2009 , pp. 819 - 827
Copyright
Copyright © American Society of Law, Medicine and Ethics 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

See Zadek, S., “The Path to Corporate Responsibility,” Harvard Business Review 82, no. 12 (2004): 125–132.Google Scholar
See Hirschhorn, N., “Corporate Social Responsibility and the Tobacco Industry: Hope or Hype?” Tobacco Control 13, no. 2 (2003): 447–543.CrossRefGoogle Scholar
See Smith, E. A. and Malone, R. E., “Thinking the ‘Unthinkable’: Why Philip Morris Considered Quitting,” Tobacco Control 12, no. 2 (2003): 208–213, at 208.CrossRefGoogle Scholar
See World Health Organization Tobacco Free Initiative, Tobacco Industry and Corporate Responsibility … An Inherent Contradiction, February 2003, available at <http://www.who.int/tobacco/media/en/tob-industry.pdf> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
See Szczypka, G., Wakefield, M. A., Emery, S., Terry-McElrath, Y. M., Flay, B. R. and Chaloupka, F. J., “Working to Make an Image: An Analysis of Three Philip Morris Corporate Image Media Campaigns,” Tobacco Control 16, no. 5 (2007): 344–350; Thomson, G., Action on Smoking and Health, Trust Us, We're Socially Responsible: The TRUTH Behind British American's Tobacco NZ's Corporate Social Responsibility Reports, September 2005, available at <http://www.ash.org.nz/pdf/TobaccoIndustry/Conduct/ash-batnz.pdf> (last visited October 14, 2009).CrossRefGoogle Scholar
See Wakefield, M., McCleod, K. and Perry, C. L., ““Stay Away from Them Until You're Old Enough to Make a Decision”: Tobacco Company Testimony about Youth Smoking Initiation”, Tobacco Control 15, Supplement IV (2006): iv44–iv53; Mandel, L. L., Aguinaga Bialous, S. and Glantz, S. A., “Avoiding ‘Truth’: Tobacco Industry Promotion of Life Skills Training,” Journal of Adolescent Health 39, no. 6 (2006): 868-879; Landman, A., Ling, P. M. and Glantz, S. A., “Tobacco Industry Youth Smoking Prevention Programs: Protecting the Industry and Hurting Tobacco Control,” American Journal of Public Health 92, no. 6 (2002): 917-930.CrossRefGoogle Scholar
See Mahood, G., Tobacco Industry Denormalization, Telling the Truth about the Tobacco Industry's Role in the Tobacco Epidemic, March 2004, at 1, available at <http://www.nsra-adnf.ca/cms/file/pdf/Denormalization_English_Booklet.pdf> (last visited October 14, 2009); Collin, J. and Gilmore, A., “Corporate (Anti)Social (Ir)Responsibility: Transnational Tobacco Companies and the Attempted Subversion of Global Health Policy,” Global Social Policy 2, no. 3 (2002): 354–360, at 355.Google Scholar
See Zadek, , supra note 1.Google Scholar
See Friedman, L. C., “Philip Morris's Website and Commercials Use New Language to Mislead the Public Into Believing It Has Changed Its Stance on Smoking and Disease,” Tobacco Control 16, no. 9 (2007), available at <http://www.tobaccocontrol.com/cgi/content/full/16/6/e9> (last visited October 14, 2009); Yang, J. S., “Working to Shape What Society's Expectations of Us Should Be: Philip Morris's Societal Alignment Strategy,” Tobacco Control 17, no. 6 (2008): 391-398.CrossRefGoogle Scholar
See Friedman, , supra note 9.Google Scholar
See Yang, , supra note 9.Google Scholar
See Sullivan, L. and Tilson, M., Program Training and Consultation Centre, Tobacco Industry Denormalization Pack, March 2005, available at <http://www.ptcc-cfc.on.ca/upload/RDS_0093.pdf> (last visited October 14, 2009); Mahood, , supra note 7; Ashley, M. J. and Cohen, J. E., “What the Public Thinks about the Tobacco Industry and Its Products,” Tobacco Control 12, no. 4 (2003): 396–400, at 399.Google Scholar
See Sullivan, , supra note 12, at 4; Mahood, , supra note 7, at 1.Google Scholar
See Mahood, , supra note 7, at 5.Google Scholar
See Leatherdale, S. T., Sparks, R. and Kirsh, V. A., “Beliefs about Tobacco Industry (Mal)Practices and Youth Smoking Behavior: Insight for Future Tobacco Control Campaigns,” Cancer Causes Control 17, no. 5 (2006): 705–711 at 705; see Mahood, , supra note 7, at 5.CrossRefGoogle Scholar
See Sullivan, and Tilson, , supra note 12, at 10–11, 16; Mahood, , supra note 7, at 15–16; Goldman, L. K. and Glantz, S. A., “Evaluation of Antismoking Advertising Campaigns,” JAMA 279, no. 10 (1998): 772–777, at 774–775.Google Scholar
See Friedman, L. C., Daynard, R. A. and Banthin, C. N., “How Tobacco-Friendly Science Escapes Scrutiny in the Courtroom,” American Journal of Public Health 95, Supplement I (2005): S16–S20 (discussing the tobacco industry's use of “junk science”).CrossRefGoogle Scholar
See Sullivan, , supra note 12 at 11; Mahood, , supra note 7, at 15.Google Scholar
See Bernat, D. H., Erickson, D. J., Widome, R., Perry, C. L. and Forster, J. L., “Adolescent Smoking Trajectories: Results From a Population-Based Cohort Study,” Journal of Adolescent Health, 43, no. 4 (2008): 334–340; Sullivan, , supra note 12, at 6, 18; Goldman, , supra note 16.CrossRefGoogle Scholar
See Mahood, , supra note 7, at 4; Goldman, and Glantz, , supra note 16, at 776.Google Scholar
See Goldman, and Glantz, , supra note 16, at 776.Google Scholar
See Bernat, et al., supra note 19.Google Scholar
See Ling, P. M., Neilands, T. B. and Glantz, S. A., “The Effect of Support for Action against the Tobacco Industry on Smoking among Young Adults,” American Journal of Public Health 97, no. 8 (2007): 1449–1456.CrossRefGoogle Scholar
See Hammond, D., Fong, G. T., Zanna, M. P., Thrasher, J. F. and Borland, R., “Tobacco Denormalization and Industry Beliefs among Smokers from Four Countries,” American Journal of Preventative Medicine 31, no. 3 (2006): 225–232; Mahood, , supra note 7, at 15.CrossRefGoogle Scholar
See Mahood, , supra note 7, at 9.Google Scholar
See Smith, and Malone, , supra note 3, at 211.Google Scholar
United States v. Philip Morris, et al., No. 99-CV-2296 (D.D.C. filed Sept. 22, 1999).Google Scholar
See Legacy Tobacco Documents Library, available at <http://legacy.library.ucsf.edu> (last visited October 14, 2009); for more information about the DOJ Special Collection, see About the Collections, United States Department of Justice, available at <http://legacy.library.ucsf.edu/about/about_collections.jsp> (last visited October 14, 2009).+(last+visited+October+14,+2009);+for+more+information+about+the+DOJ+Special+Collection,+see+About+the+Collections,+United+States+Department+of+Justice,+available+at++(last+visited+October+14,+2009).>Google Scholar
United States v. Philip Morris, et al., No. 99-CV-2296 (D.D.C. filed Sept. 22, 1999), at <http://www.usdoj.gov/civil/cases/tobacco2/complain.pdf> (last visited June 2, 2009).+(last+visited+June+2,+2009).>Google Scholar
U.S. v. Philip Morris USA, Inc., 449 F. Supp. 2d 1 (D.D.C. 2006).Google Scholar
Id., at 851–907.Google Scholar
Id., at 146–308.Google Scholar
Id., at 308–384.Google Scholar
Id., at 430–561.Google Scholar
Id., at 561–692.Google Scholar
Id., at 692–801.Google Scholar
Id., at 801–839.Google Scholar
U.S. v. Philip Morris USA, Inc., 2009 U.S. App. LEXIS 11008 (D.C. Cir. 2009). The appeals court did reverse the district court's decision on one of the remedies it had ordered and on other minor points, but left intact its findings of fact and law regarding the counts of racketeering, conspiracy and fraud.Google Scholar
See Guardino, S. D. and Daynard, R. A., “Tobacco Industry Lawyers as ‘Disease Vectors,’” Tobacco Control 16, no. 4 (2007): 224–228; Guardino, S. D. and Daynard, R. A., “Punishing Tobacco Industry Misconduct: The Case for Exceeding a Single Digit Ration between Punitive and Compensatory Damages,” University of Pittsburgh Law Review 67, no. 1 (2005): 38-63.CrossRefGoogle Scholar
Civil Division, U.S. Department of Justice, Litigation Against Tobacco Companies, available at <http://www.usdoj.gov/civil/cases/tobacco2/index.htm> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
See Zadek, , supra note 1, at 126–127.Google Scholar
Reif, H., 3rd Tobacco Scientific Meeting Bergerac, October 20, 1999, Bates No. 2505792374, available at <http://legacylibrary.ucsf.edu/tid/acj77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id.Google Scholar
“The Tobacco Industry and Its Impact on Scientific and Medical Attitudes and Opinion – A BAT View,” April 8, 1982, Bates No. 680585768, available at <http://legacy.library.ucsf.edu/tid/rnb77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
See Friedman, , supra note 9, at 3.Google Scholar
See id.Google Scholar
See id.; Yang, , supra note 9.Google Scholar
Web Site Backgrounder, September 20, 1999, Bates No. 2076742771, available at <http://legacy.library.ucsf.edu/tid/gpg77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id.Google Scholar
“Annual Meeting – 2000 Draft Board,” February 16, 2000, available at <http://legacy.library.ucsf.edu/tid/gxg77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Web Site Backgrounder, September 20, 1999, Bates No. 2076742772, available at <http://legacy.library.ucsf.edu/tid/gpg77a00> (last visited October 14, 2009); Bozell/Eskew Advertising, Mea Culpa/Rev. A, January 6, 1999, available at <http://legacy.library.ucsf.edu/tid/hse77a00> (last weekend June 2, 2009); MES Analyst Speech, October 23, 2000, available at <http://legacy.library.ucsf.edu/tid/tyg77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009);+Bozell/Eskew+Advertising,+Mea+Culpa/Rev.+A,+January+6,+1999,+available+at++(last+weekend+June+2,+2009);+MES+Analyst+Speech,+October+23,+2000,+available+at++(last+visited+October+14,+2009).>Google Scholar
Web Site Backgrounder, September 20, 1999, Bates No. 2076742780–2076742781, available at <http://legacy.library.ucsf.edu/tid/gpg77a00> (accessed last visited October 14, 2009).+(accessed+last+visited+October+14,+2009).>Google Scholar
McDaniel, P. A. and Malone, R. E., “The Role of Corporate Credibility in Legitimizing Disease Promotion,” American Journal of Public Health 99, no. 3 (2009): 452–461.CrossRefGoogle Scholar
Web Site Backgrounder, September 20, 1999, Bates No. 2076742771, available at <http://legacy.library.ucsf.edu/tid/gpg77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Letter from William Kloepfer to Donald K Hoel regarding February meeting of ETS Advisory Group, March 24, 1987, available at <http://legacy.library.ucsf.edu/tid/jnc77a00> (last visited October 14, 2009); Summary Analysis of Strategic Alternatives, October 17, 1994, available at <http://legacy.library.ucsf.edu/tid/exd77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009);+Summary+Analysis+of+Strategic+Alternatives,+October+17,+1994,+available+at++(last+visited+October+14,+2009).>Google Scholar
Summary Analysis of Strategic Alternatives, October 17, 1994, available at <http://legacy.library.ucsf.edu/tid/exd77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
IARC Communications, January 16, 1997, available at <http://legacy.library.ucsf.edu/tid/oob77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Lorillard Corporate Communication Project, Bates No. 82579120, 82579115, available at <http://legacy.library.ucsf.edu/tid/shc77a00> (last visited October 14, 2009) (emphasis in original).+(last+visited+October+14,+2009)+(emphasis+in+original).>Google Scholar
Id., at Bates No. 82579121.Google Scholar
Summary Analysis of Strategic Alternatives, October 17, 1994, available at <http://legacy.library.ucsf.edu/tid/exd77a00> (accessed June 2, 2009).+(accessed+June+2,+2009).>Google Scholar
Philip Morris, FDA & Tobacco, April 2008, available at <http://www.philipmorrisusa.com/en/cms/Responsibility/Government_Relations/Legislative_Issues/pdfs/fda_and_tobacco.pdf.aspx> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Summary Analysis of Strategic Alternatives, October 17, 1994, available at <http://legacy.library.ucsf.edu/tid/exd77a00> (accessed March 26, 2009).+(accessed+March+26,+2009).>Google Scholar
Ward, M. E., “Hong Kong,” Email, October 7, 1995, Bates No. 531995265, available at <http://legacy.library.ucsf.edu/tid/wty36a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id.Google Scholar
Trial testimony of John P. Rupp October 28, 2004 [a.m.], United States of America v. Philip Morris USA Inc., October 28, 2004, at 1183, available at <http://tobaccodocuments.org/datta/RUPPJ102804AM.html> (last visited March 26, 2009; access restricted).+(last+visited+March+26,+2009;+access+restricted).>Google Scholar
Ely, R. L. O., “Letter from RLO Ely to E Pepples Enclosing Lee's Latest Report to the TAC,” June 19, 1981, available at <http://legacy.library.ucsf.edu/tid/ylb77a00> (last visited October 14, 2009). (last visited October 14, 2009).' href=https://scholar.google.com/scholar?q=Ely,+R.+L.+O.,+“Letter+from+RLO+Ely+to+E+Pepples+Enclosing+Lee's+Latest+Report+to+the+TAC,”+June+19,+1981,+available+at++(last+visited+October+14,+2009).>Google Scholar
Id., at Bates No. 521024595.Google Scholar
Trial testimony of John P. Rupp October 28, 2004 [a.m.], United States of America v. Philip Morris USA Inc., October 28, 2004, at 1184, available at <http://tobaccodocuments.org/datta/RUPPJ102804AM.html> (last visited March 26, 2009; access restricted).+(last+visited+March+26,+2009;+access+restricted).>Google Scholar
U.S. v. Philip Morris U.S.A., Inc., 449 F. Supp.2d 1, 717 (D.D.C. 2006) (citing Colby, F.G. and Lee, P. B., June 12, 1981, Bates No. 501622432–2433, available at <http://legacy.library.ucsf.edu/tid/gtf35a00> (last visited June 2, 2009)).+(last+visited+June+2,+2009)).>Google Scholar
Id., at 692.Google Scholar
Moskowitz, S. W., “Alice in Wonderland,” Email, June 6, 1997, available at <http://legacy.library.ucsf.edu/tid/yqb77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
ETS Coordinating Committee, September 15, 1989, Bates No. 515541697, 515541698, available at <http://legacy.library.ucsf.edu/tid/pbc77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id., at Bates No. 515541698.Google Scholar
Moskowitz, S. W., “IARC Communications,” January 16, 1997, Bates No. 700900322, available at <http://legacy.library.ucsf.edu/tid/oob77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id.Google Scholar
Id.Google Scholar
For a description of Philip Morris's PM21 charitable giving program, see Tesler, L. E. and Malone, R. E., “Corporate Philanthropy, Lobbying and Public Health Policy,” American Journal of Public Health 98, no. 12 (2008): 2123–2133.CrossRefGoogle Scholar
Berlind, M., “Glantz Message on ETS/Website,” October 6, 1999, available at <http://legacy.library.ucsf.edu/tid/agh77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
“Joint Meeting on ETS – London, England,” July 15, 1988, Bates No. 87675288, available at <http://legacy.library.ucsf.edu/tid/xhc77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id., at Bates No. 87675278.Google Scholar
Id., at Bates No. 87675280, 87675284.Google Scholar
Id., at Bates No. 87675285.Google Scholar
Id., at Bates No. 87675288.Google Scholar
“Moderate Indoor Smoking with Adequate Ventilation,” Bates No. 2023895490–2023895491, available at <http://legacy.library.ucsf.edu/tid/uad77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id., at Bates No. 2023895491.Google Scholar
Wells, J. and Kendrick, J., “Thresholds,” October 13, 1988, available at <http://legacy.library.ucsf.edu/tid/mdb77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Berlind, M., “Draft Revised Policy,” April 26, 2001, available at <http://legacy.library.ucsf.edu/tid/tph77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id.Google Scholar
Philip Morris USA, “Cigarettes, Smoking & Health Issues,” available at <http://www.philipmorrisusa.com/en/cms/Products/Cigarettes/Health_Issues/Secondhand_Smoke/default.aspx> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
See Friedman, , supra note 17, at S18 n. 26.Google Scholar
Trial testimony of John Graham Robertson, October 25, 2004, United States of America v. Philip Morris USA, Inc., October 25, 2004, at 1159, 1170–71, available at <http://tobaccodocuments.org/datta/ROBERTSONJ102504.html> (last visited March 26, 2009; access restricted).+(last+visited+March+26,+2009;+access+restricted).>Google Scholar
Id., at 1155, 1166.Google Scholar
Robertson, G., “Sick Building Syndrome,” August 11, 1987, Bates No. TIDN0016358, available at <http://legacy.library.ucsf.edu/tid/knc77a00> (last visited October 14, 2009).+(last+visited+October+14,+2009).>Google Scholar
Id. at Bates No. TIDN0016359.Google Scholar
Trial testimony of John Graham Robertson, October 25, 2004, United States of America v. Philip Morris USA, Inc., October 25, 2004, at 1249, available at <http://tobaccodocuments.org/datta/ROBERTSONJ102504.html> (last visited March 26, 2009; access restricted).+(last+visited+March+26,+2009;+access+restricted).>Google Scholar